ESMO 2022 Conference Coverage

 

ESMO 2022 Conference Coverage
H

Lecture Summary - ESMO 2022 on the OS Results From the Phase 3 TROPiCS-02 Study: Sacituzumab Govitecan vs. Treatment of Physician’s Choice in Patients With HR+/HER2- mBC

By ESMO 2022 Conference Coverage FEATURING Hope Rugo
By ESMO 2022 Conference Coverage FEATURING Hope Rugo
10 views
September 21, 2022
0 Comments
Login to view comments. Click here to Login
Breast
10:22
ESMO 2022 Conference Coverage

ESMO 2022 Updates on mTNBC

Feat. L. Carey
10:18
ESMO 2022 Conference Coverage

ESMO 2022 on the First Results From the BELLINI Trial: Nivo & Ip…

Feat. M. Kok
59
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on PROs From the Randomized Phase 3 Stud…

Feat. N. Ueno
09:42
ESMO 2022 Conference Coverage

ESMO 2022 on DESTINY-Breast04 Patient-Reported Outcomes: T-DXd vs. T…

Feat. N. Ueno
43
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on the Biomarker Analyses From Patients …

Feat. F. Mosele
22:08
ESMO 2022 Conference Coverage

ESMO 2022 on the Biomarker Analyses From Patients From the DAISY Tri…

Feat. F. Mosele
01:11
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on Primary Endpoint Results of the Rando…

Feat. L. Buisseret
09:38
ESMO 2022 Conference Coverage

ESMO 2022 on Primary Endpoint Results of the Randomized Phase 2 SYNE…

Feat. L. Buisseret
24:36
ESMO 2022 Conference Coverage

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

Feat. H. Rugo, J. O'Shaughnessy
47
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on the OS Results From the Phase 3 TROPi…

Feat. H. Rugo
14:22
ESMO 2022 Conference Coverage

ESMO 2022 on the OS Results From the Phase 3 TROPiCS-02 Study: Sacit…

Feat. H. Rugo
46
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on HER2-Low Inflammatory Breast Cancer: …

Feat. P. Tarantino
04:58
ESMO 2022 Conference Coverage

ESMO 2022 on HER2-Low Inflammatory Breast Cancer: Clinicopathologic …

Feat. P. Tarantino
02:15
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on a Randomized Phase II METEORA-II Tria…

Feat. E. Munzone
08:23
ESMO 2022 Conference Coverage

ESMO 2022 on a Randomized Phase II METEORA-II Trial: Metronomic Oral…

Feat. E. Munzone
22:29
ESMO 2022 Conference Coverage

ESMO 2022 on Adjuvant Endocrine Therapy for BC: Who Needs More Than …

Feat. E. de Azambuja
40
ESMO 2022 Conference Coverage

Lecture Summary - ESMO 2022 on the DAISY Trial: Antitumor Activity o…

Feat. N. Epaillard
05:41
ESMO 2022 Conference Coverage

ESMO 2022 on the DAISY Trial: Antitumor Activity of T-DXd in Patient…

Feat. N. Epaillard